v3.26.1
Consolidated Statement of Changes in Stockholders' Deficit - USD ($)
Common Stock [Member]
Equity Payable [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total Shareholders Equity [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2023 $ 29,742,533 $ 3,157,789 $ (36,173,768) $ 147,203 $ (3,126,243) $ (2,542,021) $ (5,668,264)
Balance, shares at Dec. 31, 2023 359,571,047            
Common stock issued in settlement of accounts payable and accrued expenses 477,417 477,417
Issuance of Preferred Series B 4,400 4,400
Foreign exchange translation 48,886 48,886 48,886
Net loss (2,118,612) (2,118,612) (630,262) (2,748,874)
Balance at Dec. 31, 2024 $ 29,742,533 3,157,789 (38,292,380) 196,089 (5,195,969) (2,690,466) (7,886,435)
Balance, shares at Dec. 31, 2024 359,571,047            
Common stock issued in settlement of accounts payable and accrued expenses $ 250,000 250,000 250,000
Foreign exchange translation (27,491) (27,491) (27,491)
Net loss (2,475,520) (2,475,520) (1,280,959) (3,756,479)
Common stock issued in settlement of accounts payable and accrued expenses, shares 1,000,000,000            
Issuance of common stock upon conversion of convertible notes payable and accrued interest $ 223,435 223,435 223,435
Issuance of common stock upon conversion of convertible notes payable and accrued interest, shares 22,443,508            
Issuance of common stock for intangibles $ 100,000 100,000 100,000
Issuance of common stock for intangibles, shares 100,000,000            
Common stock issued to settle accounts payable and accrued expenses 363,166 363,166
Common stock issued to settle accrued expenses - related party 225,000 225,000
Issuance of common stock for cash 50,000 50,000
Common stock issued for cash and settlement of accrued interest, net of issuance costs 1,012,121 1,012,121
Balance at Dec. 31, 2025 $ 30,315,968 $ 3,157,789 $ (40,767,900) $ 168,598 $ (7,125,545) $ (2,321,138) $ (9,446,683)
Balance, shares at Dec. 31, 2025 1,482,014,555